Search
Returning search results with filters:
Remove filter for
Audience: Industry
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2024
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 38 items.
XQS Nicotine Pouches 4 & 6 mg: No market authorization
RecallHealth product recall | 2024-06-13
Zyn Nicotine Pouches 1.5 & 3mg: No market authorization
RecallHealth product recall | 2024-06-12
Taisho Pharmaceutical Pabron Gold A (Granules) unlicensed product:, product is labelled to contain dihydrocodeine phosphate that is listed on Schedule I of the CDSA
RecallHealth product recall | 2024-06-10
PMS-PIRFENIDONE 267 & 801 mg: Data integrity concerns with products bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-07
Mint-Betahistine 8, 16 & 24mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-06
Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-06
Jamp Digoxin tablet: Over-sized tablet
RecallHealth product recall | 2024-06-03
Extra Strength Heartburn Relief; Foreign matter
RecallHealth product recall | 2024-05-29
Probiotic antibiotic support capsule: Out-of-specification (Bacterial content)
RecallHealth product recall | 2024-05-27
Swical-Energy Extra-Strength Liquid: Incorrect expiry date
RecallHealth product recall | 2024-05-27
Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-05-16
Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)
RecallHealth product recall | 2024-05-16
REDDY-SAPROPTERIN: Color change & decrease potency
RecallHealth product recall | 2024-05-03
Miracle Reds: missing risk statement
RecallHealth product recall | 2024-04-23
PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17